1. Home
  2. ARAY vs AYTU Comparison

ARAY vs AYTU Comparison

Compare ARAY & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Accuray Incorporated

ARAY

Accuray Incorporated

HOLD

Current Price

$0.30

Market Cap

31.3M

Sector

Health Care

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

SELL

Current Price

$2.04

Market Cap

27.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ARAY
AYTU
Founded
1990
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.3M
27.4M
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
ARAY
AYTU
Price
$0.30
$2.04
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $9.50
AVG Volume (30 Days)
★ 11.5M
48.3K
Earning Date
11-04-2026
09-22-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 87.50
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $27,632,080.00
Revenue This Year
$2.75
$17.96
Revenue Next Year
$2.35
$27.98
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 277.47
52 Week Low
$0.22
$1.80
52 Week High
$2.10
$3.07

Technical Indicators

Market Signals
Indicator
ARAY
AYTU
Relative Strength Index (RSI) 61.57 44.65
Support Level $0.24 $2.05
Resistance Level $0.34 $2.36
Average True Range (ATR) 0.03 0.12
MACD 0.01 -0.00
Stochastic Oscillator 52.97 43.88

Price Performance

Historical Comparison
ARAY
AYTU

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: